Carole S. Ben-Maimon

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

LRMR

Current role

CEO, Board Member

2020-06-02–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Larimar Therapeutics, Inc. (LRMR)	President and Chief Executive Officer	$650,000	$307,450	$346,000	$1,889,160	—	$18,953	$3,526,423
2024	Larimar Therapeutics, Inc. (LRMR)	President and Chief Executive Officer	$600,000	$285,000	$278,386	$1,327,605	—	$20,658	$2,511,649
2023	Larimar Therapeutics, Inc. (LRMR)	President and Chief Executive Officer	$560,000	$288,400	$1,012,700	$1,259,733	—	$16,599	$3,137,431
2022	Larimar Therapeutics, Inc. (LRMR)	President and Chief Executive Officer	$527,850	$304,000	—	$1,283,915	—	$13,784	$2,129,549
2021	Larimar Therapeutics, Inc. (LRMR)	President and Chief Executive Officer	$510,000	$140,250	—	$1,570,389	—	$13,184	$2,233,823
2020	Larimar Therapeutics, Inc. (LRMR)	President and Chief Executive Officer	$267,626	$272,600	—	$4,718,552	—	$11,400	$5,270,178

No earnings-call appearances or filed executive changes recorded yet.